Literature DB >> 17012294

Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years.

Christian R A Mondadori1, Andreas Buchmann, Henrietta Mustovic, Conny F Schmidt, Peter Boesiger, Roger M Nitsch, Christoph Hock, Johannes Streffer, Katharina Henke.   

Abstract

Presenilin 1 (PSEN1) mutations cause autosomal dominant familial Alzheimer's disease (FAD). PSEN1 mutation carriers undergo the course of cognitive deterioration, which is typical for sporadic Alzheimer's disease but disease onset is earlier and disease progression is faster. Here, we sought to detect signs of FAD in presymptomatic carriers of the PSEN1 mutation (C410Y) by use of a neuropsychological examination, functional MRI during learning and memory tasks and MRI volumetry. We examined five non-demented members of a FAD family and 21 non-related controls. Two of the five family members were carrying the mutation; one was 20 years old and the other 45 years old. The age of clinical manifestation of FAD in the family studied here is approximately 48 years. Neuropsychological assessments suggested subtle problems with episodic memory in the 20-year-old mutation carrier. The middle-aged mutation carrier fulfilled criteria for amnestic mild cognitive impairment. The 20-year-old mutation carrier exhibited increased, while the middle-aged mutation carrier exhibited decreased brain activity compared to controls within memory-related neural networks during episodic learning and retrieval, but not during a working-memory task. The increased memory-related brain activity in the young mutation carrier might reflect a compensatory effort to overcome preclinical neural dysfunction caused by first pathological changes. The activity reductions in the middle-aged mutation carrier might reflect gross neural dysfunction in a more advanced stage of neuropathology. These data suggest that functional neuroimaging along with tasks that challenge specifically those brain areas which are initial targets of Alzheimer's disease pathology may reveal activity alterations on a single-subject level decades before the clinical manifestation of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17012294     DOI: 10.1093/brain/awl266

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  43 in total

1.  Reduced benefit from mnemonic strategies in early-stage Alzheimer's disease: a brief testing-the-limits paradigm for clinical practice.

Authors:  Ingo Uttner; Niklas Schurig; Christine A F von Arnim; Christian Lange-Asschenfeldt; Hayrettin Tumani; Matthias W Riepe
Journal:  J Neurol       Date:  2010-06-11       Impact factor: 4.849

2.  Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease.

Authors:  Yakeel T Quiroz; Andrew E Budson; Kim Celone; Adriana Ruiz; Randall Newmark; Gabriel Castrillón; Francisco Lopera; Chantal E Stern
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

3.  Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task.

Authors:  John M Ringman; Luis D Medina; Meredith Braskie; Yaneth Rodriguez-Agudelo; Daniel H Geschwind; Miguel A Macias-Islas; Jeffrey L Cummings; Susan Bookheimer
Journal:  Cereb Cortex       Date:  2010-08-20       Impact factor: 5.357

Review 4.  How early? ASAP: molecular and functional imaging!

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-04       Impact factor: 9.236

5.  Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation.

Authors:  Saul L Miller; Kim Celone; Kristina DePeau; Eli Diamond; Bradford C Dickerson; Dorene Rentz; Maija Pihlajamäki; Reisa A Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-31       Impact factor: 11.205

6.  Vascular changes and brain plasticity: a new approach to neurodegenerative diseases.

Authors:  Anya Topiwala; Klaus P Ebmeier
Journal:  Am J Neurodegener Dis       Date:  2012-07-23

7.  Lifespan brain activity, β-amyloid, and Alzheimer's disease.

Authors:  William J Jagust; Elizabeth C Mormino
Journal:  Trends Cogn Sci       Date:  2011-10-07       Impact factor: 20.229

8.  Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN).

Authors:  Martha Storandt; David A Balota; Andrew J Aschenbrenner; John C Morris
Journal:  Neuropsychology       Date:  2013-11-11       Impact factor: 3.295

Review 9.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

Review 10.  Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging.

Authors:  Bradford C Dickerson; Reisa A Sperling
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.